Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof

Disclosed are a dual modulator of mGluR5 and 5-HT2AR (5-HT2A receptor), and use thereof. More specifically, disclosed are a compound which acts as modulator of mGluR5 and an antagonist of 5-HT2AR at the same time, and use thereof as therapeutic agent for pain.

Saved in:
Bibliographic Details
Main Authors Choi, Dae Kyu, Bae, Mi Seon, Lee, Geon Ho, Lee, Han Mi, Kim, Hyo Jin, Heo, Hyun Jin, Choi, Jin, Park, Jin Sun, Shim, Mi Yon, Lee, Yong Seok
Format Patent
LanguageEnglish
Published 13.08.2024
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are a dual modulator of mGluR5 and 5-HT2AR (5-HT2A receptor), and use thereof. More specifically, disclosed are a compound which acts as modulator of mGluR5 and an antagonist of 5-HT2AR at the same time, and use thereof as therapeutic agent for pain.
Bibliography:Application Number: US202117631212